Feucherolles, France

Brian Lockhart

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 83(Granted Patents)


Location History:

  • Croissy sur Seine, FR (2000 - 2006)
  • Feucherolles, FR (2008 - 2009)

Company Filing History:


Years Active: 2000-2009

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Brian Lockhart

Introduction

Brian Lockhart is a notable inventor based in Feucherolles, France. He has made significant contributions to the field of medicinal chemistry, holding a total of 8 patents. His work focuses on developing compounds that have therapeutic applications, particularly in treating conditions associated with the central histaminergic systems and specific nicotinic receptors.

Latest Patents

Among his latest patents, Lockhart has developed azabicyclic compounds, which include a process for their preparation and pharmaceutical compositions containing them. These compounds are particularly useful for treating conditions related to central histaminergic systems. Additionally, he has patented polysubstituted 1,1-pyridylaminocyclopropanamine compounds, which are designed for medicinal products that target specific nicotinic ligands of α4β2 receptors.

Career Highlights

Throughout his career, Brian Lockhart has worked with prominent companies in the pharmaceutical industry, including Adir Et Compagnie and Les Laboratoires Servier. His expertise in medicinal chemistry has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Lockhart has collaborated with several professionals in his field, including Pierre Lestage and Solo Goldstein. These collaborations have further enhanced his research and development efforts in medicinal chemistry.

Conclusion

Brian Lockhart's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of therapeutic compounds that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…